September 15th• 3 min read
SEC Extends XRP ETF Review Despite 92% Approval Odds
The SEC has delayed Franklin Templeton's XRP ETF decision to November 14, extending the review by 60 days from the original September 15 deadline, though market odds for approval remain above 92%.
Key takeaways
📅 Timeline Extension: SEC pushed Franklin Templeton's XRP ETF deadline from September 15 to November 14, 2025, using its 60-day extension authority.
🎯 October Cluster: Multiple major ETF applications from Grayscale, Bitwise, and others still face October 18-25 deadlines with no further extension options.
📊 Market Confidence: Polymarket shows 92% probability of XRP ETF approval by year-end, up from 91% last week despite the delay.
⚖️ Standard Procedure: Delays are typical for crypto ETF reviews and don't indicate rejection, as seen with Bitcoin and Ethereum ETF approvals.
Deep dive
The SEC's extension of Franklin Templeton's XRP ETF review represents standard regulatory procedure rather than a negative signal, as the agency has consistently delayed first-round crypto ETF filings to allow for thorough review and public comment periods.
While this specific application now faces a November deadline, the broader XRP ETF landscape remains on track with multiple heavyweight applications from Grayscale, Bitwise, and others scheduled for final decisions in October.
Market sentiment remains bullish with Polymarket odds actually increasing to 92% despite the delay, reflecting investor confidence in eventual approval.
The regulatory pattern mirrors previous crypto ETF approvals for Bitcoin and Ethereum, where initial delays preceded eventual green lights, suggesting XRP ETFs remain likely for 2025 launch.
Polaris insights AI-generated
Disclaimer: This article may contain content generated or assisted by AI, based on information from public sources. While we aim for accuracy, no content should be taken as financial or trading advice. Always do your own research and consult a professional before making investment decisions. Markets are volatile and involve risk.
